Determination of the immunostimulatory drug—glucosoaminyl‐muramyl‐dipeptide—in human plasma using HPLC–MS/MS and its application to a pharmacokinetic study-Reference-Cited by-同舟云学术

Determination of the immunostimulatory drug—glucosoaminyl‐muramyl‐dipeptide—in human plasma using HPLC–MS/MS and its application to a pharmacokinetic study

Published:2020-07-29 Issue:12 Volume:34 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Moskaleva Natalia E.¹^ORCID,Markin Pavel A.¹²^ORCID,Kuznetsov Roman M.¹^ORCID,Andronova Tatiana M.³^ORCID,Appolonova Svetlana A.¹^ORCID

Affiliation:

1. Laboratory of Pharmacokinetics and Metabolomic Analysis, Institute of Translational Medicine and Biotechnology I.M. Sechenov First Moscow State Medical University Moscow Russia

2. PhD Program in Nanosciences and Advanced Technologies University of Verona Verona Italy

3. ‘Peptek’ Moscow Russia

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.4948

Reference50 articles.

1. Muramyl peptides: Immunomodulators, sleep factors, and vitamins

2. Pathogen Recognition and Innate Immunity

3. The structure and immunomodulating function of glucosaminylmuramyl peptides;Andronova T.;Sov Med Rev D Immunology,1991

4. Possible Indirect Detection of rHuEPO Administration in Human Urine by High-Performance Liquid Chromatography Tandem Mass Spectrometry

5. Bioanalytical Method Validation Guidance for Industry. US Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM) May2018Silver Spring Maryland. USA (Accessed 4 November 2019).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency;Frontiers in Oncology;2022-09-27